HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alendronate (Alendronate Sodium)

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
Also Known As:
Alendronate Sodium; Fosamax; 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate; Alendronate Monosodium Salt, Trihydrate; Aminohydroxybutane Bisphosphonate; MK-217; MK 217; MK217
Networked: 2711 relevant articles (325 outcomes, 673 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Iwamoto, Jun: 41 articles (08/2021 - 01/2002)
2. Takeda, Tsuyoshi: 32 articles (08/2021 - 01/2002)
3. Sato, Yoshihiro: 31 articles (08/2021 - 08/2004)
4. Uzawa, Mitsuyoshi: 21 articles (08/2021 - 06/2003)
5. Black, Dennis M: 17 articles (09/2021 - 09/2003)
6. Bilezikian, John P: 15 articles (11/2020 - 06/2002)
7. Miller, Paul D: 15 articles (11/2020 - 05/2002)
8. Matsumoto, Hideo: 15 articles (09/2012 - 01/2008)
9. Cosman, Felicia: 14 articles (11/2021 - 08/2005)
10. Li, Mei: 14 articles (12/2020 - 09/2002)

Related Diseases

1. Osteoporosis
2. Postmenopausal Osteoporosis
3. Pain (Aches)
4. Bone Resorption
5. Metabolic Bone Diseases (Osteopenia)

Related Drugs and Biologics

1. Diphosphonates (Bisphosphonates)
2. Risedronic Acid (Actonel)
3. Zoledronic Acid (Zometa)
4. Etidronic Acid (HEDP)
5. Calcium
6. Vitamin D
7. Teriparatide (Parathar)
8. Glucocorticoids
9. Raloxifene Hydrochloride (Evista)
10. Denosumab

Related Therapies and Procedures

1. Therapeutics
2. Aftercare (After-Treatment)
3. Drug Therapy (Chemotherapy)
4. Root Planing
5. Oral Administration